Fortney Kristen, CEO of BioAge Labs ($BIOA), sold shares once on the open market in the last year, totaling $4.2 million. Her most recent sale occurred on January 13, 2026. This places her 2,178th among 11,678 insiders by sale value, below the average of $8.6 million across about six transactions per insider. She made no open market purchases during this period.
| Transaction Date | Company | Ticker | Insider Name | Title | Transaction Type | Security | Shares | Price | Shares Owned Following | Total Shares Outstanding | % of Owned | % of Outstanding |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Feb. 17, 2026 | BioAge Labs, Inc. | $BIOA | Fortney Kristen | Chief Executive Officer | A | Stock Option (Right to Buy) | 330000 | $0.00 | 330,000.0000 | 35,855,037 | 9999.99% | 0.92% |
| Jan. 13, 2026 | BioAge Labs, Inc. | $BIOA | Fortney Kristen | Chief Executive Officer | S | Common Stock | 233107 | $18.12 | 976,949.0000 | 35,855,037 | 19.26% | 0.65% |
| Feb. 18, 2025 | BioAge Labs, Inc. | $BIOA | Fortney Kristen | Chief Executive Officer | A | Stock Option (Right to Buy) | 530000 | $0.00 | 530,000.0000 | 0 | 9999.99% | 0.00% |
| Sept. 25, 2024 | BioAge Labs, Inc. | $BIOA | Fortney Kristen | Chief Executive Officer | A | Stock Option (Right to Buy) | 424827 | $0.00 | 424,827.0000 | 0 | 9999.99% | 0.00% |
| April 17, 2024 | BioAge Labs, Inc. | $BIOA | Fortney Kristen | Chief Executive Officer | A | Stock Option (Right to Buy) | 708044 | $0.00 | 708,044.0000 | 0 | 9999.99% | 0.00% |